These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 18088064)

  • 1. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
    Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.
    Schmechel S; Konrad A; Diegelmann J; Glas J; Wetzke M; Paschos E; Lohse P; Göke B; Brand S
    Inflamm Bowel Dis; 2008 Feb; 14(2):204-12. PubMed ID: 18022867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.
    Dubinsky MC; Wang D; Picornell Y; Wrobel I; Katzir L; Quiros A; Dutridge D; Wahbeh G; Silber G; Bahar R; Mengesha E; Targan SR; Taylor KD; Rotter JI;
    Inflamm Bowel Dis; 2007 May; 13(5):511-5. PubMed ID: 17309073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
    Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
    Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between genetic variants in myosin IXB and Crohn's disease.
    Cooney R; Cummings JR; Pathan S; Beckly J; Geremia A; Hancock L; Guo C; Morris A; Jewell DP
    Inflamm Bowel Dis; 2009 Jul; 15(7):1014-21. PubMed ID: 19235913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
    Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
    Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
    World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
    Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
    Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
    Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
    Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
    Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
    Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
    Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
    Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.